Berkshire Hathaway Inc.
BRK-B
$488.30
+1.18%
Berkshire Hathaway Inc. is a diversified holding company operating primarily in the insurance, freight rail transportation, and utility sectors, with a vast portfolio of wholly-owned subsidiaries spanning manufacturing, services, retailing, and energy. It is a quintessential conglomerate, distinct as a long-term value investor and a fortress of financial stability, managed under the legendary stewardship of Warren Buffett and Charlie Munger. The current investor narrative revolves around navigating the post-Buffett succession era, assessing the performance of its massive equity portfolio in a volatile market, and debating whether its traditional value-oriented, cash-generative business model can continue to outperform in a technology-driven market landscape, especially as its recent financial results show mixed performance across its operating segments.…
BRK-B
Berkshire Hathaway Inc.
$488.30
Investment Opinion: Should I buy BRK-B Today?
Rating & Thesis: Hold. BRK-B represents a high-quality, defensive holding with unparalleled financial strength, but near-term headwinds in revenue growth and persistent market underperformance limit its upside catalyst, warranting a neutral stance pending clearer signs of operational improvement or a more compelling valuation entry point.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is reasonable but not deeply discounted at a trailing P/E of 16.19x, though it is below its historical peak. Second, revenue growth is negative (-7.1% YoY in Q4), indicating near-term operational challenges. Third, profitability remains strong (net margin 20.37%), providing a earnings floor. Fourth, the stock's significant underperformance versus the S&P 500 (-30% over one year) suggests it is already pricing in considerable pessimism, limiting immediate downside but also lacking a positive catalyst for outperformance.
Risks & Conditions: The two biggest risks to the thesis are: 1) Continued revenue contraction eroding the earnings base, and 2) A failure to deploy its massive cash hoard ($25B TTM FCF) in a value-accretive manner. This Hold rating would upgrade to a Buy if the trailing P/E compresses further towards 14x (implying a price near $417) or if quarterly revenue growth turns sustainably positive. It would downgrade to a Sell if revenue decline accelerates beyond -10% YoY or if the balance sheet strength is compromised. The stock is currently fairly valued relative to its own recent history but appears overvalued if the expected earnings recovery implied by the 22.65x forward P/E does not materialize.
Sign up to view all
BRK-B 12-Month Price Forecast
The 12-month outlook for BRK-B is one of muted returns with high downside protection. The base case (60% probability) of range-bound trading between $480 and $510 is most likely, as the company's operational headwinds are balanced by its financial robustness. The bull case requires a clear reversal in revenue trends and successful capital deployment, which are not yet evident. The bear case, while lower probability, is anchored by the concrete 52-week low of $455.19. The stance is neutral due to the lack of a clear near-term catalyst for outperformance, but the confidence is only medium because the company's massive cash pile ($25B FCF) represents a latent potential catalyst if deployed aggressively. The stance would upgrade to bullish on a sustained break above the 52-week high of $516.85 on strong volume, or downgrade to bearish on a confirmed break below the 52-week low with deteriorating fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Berkshire Hathaway Inc.'s 12-month outlook, with a consensus price target around $634.79 and implied upside of +30.0% versus the current price.
Average Target
$634.79
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$391 - $635
Analyst target range
Insufficient analyst coverage available. The data indicates only one analyst providing estimates, with no consensus price target or recommendation distribution presented. This limited coverage is highly unusual for a company of Berkshire Hathaway's size and prominence and may be an artifact of the provided dataset rather than reality. In a typical scenario, such minimal coverage would imply the stock is neglected by the sell-side, which can lead to higher volatility and less efficient price discovery. For BRK-B, however, its vast market cap and status mean it is closely watched by investors globally, even if formal sell-side coverage is sparse. The single analyst's revenue estimate for the next period averages $367.15 billion. The institutional ratings history shows a single firm, UBS, maintaining a consistent 'Buy' rating across multiple dates from 2024 through late 2025, indicating stable, long-term bullish sentiment from that coverage source.
Bulls vs Bears: BRK-B Investment Factors
The investment debate for Berkshire Hathaway centers on a clash between its unparalleled financial strength and defensive characteristics versus its recent operational underperformance and growth concerns. The bull case is anchored in the company's fortress balance sheet (D/E 0.19), robust cash generation ($25B TTM FCF), and reasonable valuation (P/E 16.2x) after a significant de-rating from historical highs. The bear case highlights severe revenue contraction (-7.1% YoY), chronic stock underperformance (-30% vs. S&P 500 over one year), and earnings volatility that obscures core operating trends. Currently, the bearish evidence appears stronger in the near term, given the concrete data on revenue declines and market underperformance. The single most important tension is whether Berkshire's traditional value-oriented, cash-generative conglomerate model can adapt and deliver consistent growth in a technology-driven market, or if it will remain a defensive, lower-return asset in a growth-dominated environment.
Bullish
- Fortress Balance Sheet & Liquidity: The company's financial position is exceptionally strong, with a debt-to-equity ratio of only 0.19 and a current ratio of 6.75. This provides immense financial flexibility and downside protection, enabling opportunistic investments and share buybacks during market stress.
- Strong Profitability & Cash Generation: Despite revenue volatility, Berkshire maintains robust profitability with a net margin of 20.37% in Q4 2025 and generates massive free cash flow (TTM FCF of $25.04 billion). This consistent cash generation funds its investment strategy and provides a margin of safety.
- Attractive Valuation Relative to History: The stock trades at a trailing P/E of 16.19x, well below its recent historical peak of over 62x in early 2025 and closer to the middle of its recent range. This suggests the market has tempered expectations, potentially offering a more attractive entry point for long-term investors.
- Defensive Profile with Low Volatility: With a beta of 0.622, BRK-B is approximately 38% less volatile than the S&P 500. This defensive characteristic provides relative downside protection in market downturns, as evidenced by its smaller drawdowns compared to the broader market.
Bearish
- Severe Revenue Contraction & Volatility: Q4 2025 revenue declined 7.13% year-over-year to $94.23 billion, indicating broad-based softness across operating segments. The multi-quarter trend shows significant volatility, from $83.29B in Q1 to $98.88B in Q2, highlighting inconsistent top-line performance.
- Chronic Underperformance vs. Market: BRK-B has significantly underperformed the S&P 500, down 4.85% over the past year versus the S&P's 25.19% gain, resulting in a -30.04% relative strength. This suggests the market is discounting its business model and growth prospects relative to the broader index.
- Earnings Subject to Large Swings: Net income is highly volatile, swinging from $4.60 billion in Q1 2025 to $30.80 billion in Q3 2025, largely driven by investment gains/losses. This makes underlying operating earnings difficult to assess and introduces significant quarterly earnings risk.
- Elevated Forward P/E Suggests Growth Needed: The forward P/E of 22.65x is significantly higher than the trailing P/E of 16.19x, implying the market is pricing in a substantial earnings recovery. If this growth fails to materialize, the stock faces multiple compression risk.
BRK-B Technical Analysis
The stock is in a sustained downtrend and consolidation phase, having declined 4.85% over the past year, significantly underperforming the S&P 500's 25.19% gain. Currently trading at $482.70, it sits approximately 11.9% below its 52-week high of $516.85 and only 6.0% above its 52-week low of $455.19, positioning it in the lower quartile of its annual range. This suggests the stock is trading at levels that may represent a value opportunity, but also reflects persistent weakness and a lack of bullish momentum relative to the broader market. Recent momentum shows a modest 1.82% gain over the past month, which contrasts with the more pronounced 2.98% loss over the past three months and the 5.16% loss over six months. This one-month uptick, occurring against a backdrop of severe long-term underperformance (with a relative strength of -30.04% over one year), could signal a tentative stabilization or mean reversion attempt, but it is too early to confirm a trend reversal given the stock remains well below its recent highs seen in late 2025. Key technical support is clearly defined at the 52-week low of $455.19, while resistance lies at the 52-week high of $516.85. A decisive break below support would signal a continuation of the bearish trend, potentially triggering further selling, while a sustained move above resistance would be necessary to invalidate the downtrend. The stock's beta of 0.622 indicates it is approximately 38% less volatile than the broader market (SPY), which is characteristic of its defensive, conglomerate structure and provides a measure of downside protection during market stress, though it also limits upside participation in strong rallies.
Beta
0.62
0.62x market volatility
Max Drawdown
-14.9%
Largest decline past year
52-Week Range
$455-$517
Price range past year
Annual Return
-5.0%
Cumulative gain past year
| Period | BRK-B Return | S&P 500 |
|---|---|---|
| 1m | +2.9% | +4.0% |
| 3m | -3.0% | +8.2% |
| 6m | -2.6% | +11.5% |
| 1y | -5.0% | +24.3% |
| ytd | -1.7% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRK-B Fundamental Analysis
Revenue growth has been inconsistent and recently negative, with Q4 2025 revenue of $94.23 billion representing a 7.13% year-over-year decline. The multi-quarter trend shows volatility: revenue was $94.97 billion in Q3 2025, $98.88 billion in Q2 2025, and $83.29 billion in Q1 2025. Segment data indicates the Insurance Group generated $26.41 billion, Manufacturing $19.71 billion, and Service/Retailing $21.37 billion, but without percentage growth figures, it's difficult to pinpoint precise drivers; the overall -7.1% YoY decline in Q4 suggests broad-based softness or cyclical pressures across several operating businesses. The company remains highly profitable, reporting net income of $19.20 billion for Q4 2025, though this is down from $30.80 billion in the prior quarter. The gross margin for Q4 was 23.01%, and the net margin was a robust 20.37%, demonstrating the company's ability to convert revenue into earnings efficiently. However, profitability is subject to significant quarterly swings, largely influenced by investment gains/losses within the insurance operations, as seen in the fluctuation of net income from $4.60 billion in Q1 2025 to $30.80 billion in Q3 2025. The balance sheet is exceptionally strong, with a conservative debt-to-equity ratio of 0.19 and a high current ratio of 6.75, indicating ample liquidity. The company generates substantial free cash flow, with TTM free cash flow of $25.04 billion, providing immense internal funding capacity for investments, acquisitions, and share buybacks. Return on equity (ROE) stands at 9.33%, which is respectable for a company of its size and capital intensity, reflecting efficient use of shareholder capital, albeit not at peak historical levels.
Quarterly Revenue
$94.2B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$25.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRK-B Overvalued?
Given the consistently positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 16.19x, while the forward PE is 22.65x based on estimated EPS. The higher forward multiple suggests the market anticipates a recovery in earnings growth, pricing in an expectation that recent profit softness is temporary. Compared to the broader Financial Services sector, precise industry average multiples are not provided in the data, but a trailing PE of 16.2x for a high-quality, diversified conglomerate with a fortress balance sheet is generally considered reasonable, if not slightly discounted, given its defensive characteristics and historical premium. Historically, the stock's own PE ratio has fluctuated significantly, from a low near 5x in late 2023 to a high over 62x in early 2025. The current trailing PE of 16.19x sits well below the peak observed in Q1 2025 (62.4x) and is closer to the middle of its recent historical range (e.g., 12.4x at end of 2024, 14.1x at end of 2025). This positioning suggests the market has tempered its expectations from earlier highs, potentially offering a more attractive entry point if one believes in the long-term earnings power of the conglomerate, though it also reflects the acknowledged near-term earnings headwinds.
PE
16.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -52x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Berkshire's primary financial risk stems from earnings volatility, not solvency. Net income swung from $4.6B to $30.8B across recent quarters, driven largely by mark-to-market investment gains/losses in its massive equity portfolio. This makes forecasting operating earnings challenging. While revenue declined 7.1% YoY in Q4 2025, indicating potential cyclical pressures across insurance, manufacturing, and retail segments, the company's immense liquidity (current ratio 6.75) and minimal debt (D/E 0.19) mitigate traditional financial distress risks. The key operational risk is the conglomerate's sheer size and diversity, which may limit agility and organic growth, making it dependent on large-scale acquisitions for meaningful expansion.
Market & Competitive Risks: The stock faces significant valuation compression risk if its earnings growth fails to justify its forward P/E of 22.65x. Trading at a premium to its trailing multiple suggests the market expects a recovery; disappointment could trigger de-rating. Competitive disruption is a persistent threat, particularly in insurance (its core profit engine) from insurtech and in rail/utilities from regulatory and technological changes. The stock's low beta (0.622) indicates defensive characteristics but also suggests it may continue to underperform in strong bull markets, as evidenced by its -30% relative strength over the past year. Sector rotation away from value and towards growth or technology could further pressure performance.
Worst-Case Scenario: The most damaging scenario involves a sustained economic downturn that simultaneously pressures operating earnings across its cyclical businesses (manufacturing, retail, rail) and triggers significant losses in its equity investment portfolio. This could be compounded by a failed large acquisition or missteps in the post-Buffett succession era, eroding investor confidence. Quantifying the realistic downside, the stock could retest its 52-week low of $455.19, representing a -5.7% decline from the current price of $482.70. A more severe bear case, incorporating multiple compression and earnings disappointment, could see a drawdown towards the -14.95% max drawdown level observed in the data, implying a price near $410. An investor could realistically face a loss of 5-15% in this adverse scenario before the company's fortress balance sheet would provide fundamental support.
FAQ
The key risks are, in order of severity: 1) Operational Stagnation: Revenue declined 7.1% YoY in Q4 2025, indicating potential cyclical pressures across its diverse businesses. 2) Earnings Volatility: Net income swings wildly quarter-to-quarter (e.g., $4.6B to $30.8B), driven by investment portfolio marks, making underlying performance opaque. 3) Succession & Strategy Risk: The eventual transition from Warren Buffett's leadership creates uncertainty over future capital allocation and cultural stewardship. 4) Chronic Underperformance: The stock has a -30% relative strength vs. the S&P 500 over one year, a trend that could persist if the market favors growth over value.
The 12-month forecast presents three scenarios with associated probabilities. The base case (60% probability) sees the stock trading range-bound between $480 and $510, as operational challenges offset financial strength. The bull case (25% probability) targets a return to the 52-week high of $516.85 and beyond, up to $540, on a recovery in revenue growth and successful capital deployment. The bear case (15% probability) envisions a retest of the 52-week low of $455.19 if revenue declines worsen or the market sours on the stock. The most likely outcome is the base case, which assumes the company's current trends of modest operational pressure but immense financial stability continue.
BRK-B appears fairly valued relative to its own recent history but potentially overvalued based on forward expectations. The trailing P/E of 16.19x is reasonable for a high-quality conglomerate and sits well below its historical peak above 62x. However, the forward P/E of 22.65x is significantly higher, implying the market expects a substantial earnings recovery. If this expected growth does not materialize, the stock is overvalued. Compared to the broader market, its valuation is not excessive, but the key question is whether its growth profile justifies any premium. Currently, the -7.1% YoY revenue decline suggests the market's growth expectations embedded in the forward multiple may be too optimistic.
BRK-B is a good buy for a specific type of investor: those seeking a defensive, lower-volatility holding with a fortress balance sheet and a margin of safety. The stock offers a reasonable valuation at a 16.19x trailing P/E and generates massive free cash flow ($25B TTM). However, it is not a good buy for investors seeking aggressive growth or short-term outperformance, given its -30% relative underperformance versus the S&P 500 over the past year and recent revenue declines. It is most suitable for patient, long-term investors who believe in the enduring value of its conglomerate model and can tolerate potential continued underperformance in bull markets.
BRK-B is unequivocally suitable for long-term investment, not short-term trading. Its low beta (0.622) implies muted short-term price movements, reducing its appeal for traders. Furthermore, its value proposition is based on the long-term compounding of intrinsic value across its subsidiary businesses and investment portfolio, a process that unfolds over years, not quarters. The stock pays no dividend, eliminating an income incentive for short-term holders. Given the current operational headwinds and succession planning, a minimum holding period of 3-5 years is suggested to allow the company's fundamental strengths and capital allocation to work through the cycle and potentially overcome near-term challenges.
